Development of a metabolic biosignature for detection of early Lyme disease

scientific article published on 11 March 2015

Development of a metabolic biosignature for detection of early Lyme disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/CID/CIV185
P932PMC publication ID4810808
P698PubMed publication ID25761869
P5875ResearchGate publication ID273467602

P50authorJohn T BelisleQ38548374
Gary P WormserQ105913150
P2093author name stringAnn M Hess
Mark J Delorey
Martin E Schriefer
Sebabrata Mahapatra
Laura V Ashton
Claudia R Molins
P2860cites workDiagnosis of lyme borreliosisQ22242237
Two-Tiered Antibody Testing for Lyme Disease With Use of 2 Enzyme Immunoassays, a Whole-Cell Sonicate Enzyme Immunoassay Followed by a VlsE C6 Peptide Enzyme ImmunoassayQ22242917
Early Lyme DiseaseQ22250897
Erythema MigransQ22252199
HMDB: a knowledgebase for the human metabolomeQ24655295
Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases: The Short-Term and Long-Term Outcomes: Workshop ReportQ26827556
Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS)Q28681060
Lyme borreliosisQ29013670
Regularization Paths for Generalized Linear Models via Coordinate DescentQ29614491
METLIN: a metabolite mass spectral databaseQ29614808
ROCR: visualizing classifier performance in RQ29615821
Application of machine learning to proteomics data: classification and biomarker identification in postgenomics biologyQ30676067
Robust classification modeling on microarray data using misclassification penalized posteriorQ30992256
Normalization method for metabolomics data using optimal selection of multiple internal standardsQ31105641
Serum inflammatory mediators as markers of human Lyme disease activityQ31158874
Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme diseaseQ33738269
Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluationQ34298182
Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme DiseaseQ34301091
Western blotting in the serodiagnosis of Lyme diseaseQ34355106
Innate immunity networks during infection with Borrelia burgdorferiQ34426426
Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illnessQ34541505
Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteinsQ34721407
The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolismQ34762629
Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease.Q36040985
Lyme disease testing by large commercial laboratories in the United States.Q36283952
Immune responses induced by spirochetal outer membrane lipoproteins and glycolipidsQ37136167
A metabolic biosignature of early response to anti-tuberculosis treatmentQ37569320
Exploring disease through metabolomicsQ37658632
Integrative system biology strategies for disease biomarker discoveryQ37973426
Implementation of liquid chromatography/mass spectrometry into the clinical laboratoryQ38053816
The role of eicosanoids in experimental Lyme arthritis.Q38218131
Metabonomic investigation of human Schistosoma mansoni infectionQ38870788
Metabolic profiling framework for discovery of candidate diagnostic markers of malaria.Q39534292
Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme diseaseQ40201592
Serum levels of interleukin-18 (IL-18), interleukin-1beta (IL-1beta), its soluble receptor sIL-1RII and C-reactive protein (CRP) in patients with Lyme arthritisQ44645047
Prevalence of Borrelia burgdorferi (Spirochaetales: Spirochaetaceae), Anaplasma phagocytophilum (Rickettsiales: Anaplasmataceae), and Babesia microti (Piroplasmida: Babesiidae) in Ixodes scapularis (Acari: Ixodidae) collected from recreational landsQ51463029
New Tables for Multiple Comparisons with a ControlQ56913601
Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometryQ56974325
A preliminary study of C-reactive protein in the diagnosis and monitoring of Lyme diseaseQ71957451
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectLyme diseaseQ201989
P304page(s)1767-1775
P577publication date2015-03-11
P1433published inClinical Infectious DiseasesQ5133764
P1476titleDevelopment of a metabolic biosignature for detection of early Lyme disease
P478volume60

Reverse relations

cites work (P2860)
Q98466652A Practical Approach to the Diagnosis of Lyme Borreliosis: From Clinical Heterogeneity to Laboratory Methods
Q55133030A multi-omic analysis reveals the regulatory role of CD180 during the response of macrophages to Borrelia burgdorferi.
Q49628856Accuracy of Clinician Suspicion of Lyme Disease in the Emergency Department.
Q36275562Antibody responses to Borrelia burgdorferi detected by western blot vary geographically in Canada
Q89610372Borrelia burgdorferi hijacks cellular metabolism of immune cells: Consequences for host defense
Q30357899Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States.
Q36764399Five-Antigen Fluorescent Bead-Based Assay for Diagnosis of Lyme Disease
Q58778284Identification of Urine Metabolites as Biomarkers of Early Lyme Disease
Q36687055Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease
Q36112203Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples
Q56764150Lyme borreliosis
Q40091071Metabolic differentiation of early Lyme disease from southern tick-associated rash illness (STARI).
Q42696026Metabolic phenotyping in the mouse model of urinary tract infection shows that 3-hydroxybutyrate in plasma is associated with infection
Q64947879Metabolites of prostaglandin synthases as potential biomarkers of Lyme disease severity and symptom resolution.
Q37695689Metabolomics of the tick-Borrelia interaction during the nymphal tick blood meal
Q35935426Metabolomics-Based Discovery of Small Molecule Biomarkers in Serum Associated with Dengue Virus Infections and Disease Outcomes
Q64926379NMR metabolome of Borrelia burgdorferi in vitro and in vivo in mice.
Q60952351NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system
Q100737071Predicting human health from biofluid-based metabolomics using machine learning
Q52589111Proteomic analysis at the sites of clinical infection with invasive Streptococcus pyogenes.
Q28075680The Past, Present, and (Possible) Future of Serologic Testing for Lyme Disease
Q37679914The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection
Q55496706Variable selection in omics data: A practical evaluation of small sample sizes.
Q30376327What was old is new again: using the host response to diagnose infectious disease.

Search more.